Association of maternal vitamin B 12 and folate levels in early pregnancy with gestational diabetes: a prospective UK cohort study (PRiDE study).

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0006777 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0428 (Electronic) Linking ISSN: 0012186X NLM ISO Abbreviation: Diabetologia Subsets: MEDLINE
    • Publication Information:
      Original Publication: Berlin Springer Verlag
    • Subject Terms:
      Diabetes, Gestational/*blood ; Folic Acid/*blood ; Pregnancy/*blood ; Pregnancy in Diabetics/*blood ; Vitamin B 12/*blood; Adolescent ; Adult ; Blood Glucose/metabolism ; Diabetes, Gestational/epidemiology ; Female ; Folic Acid Deficiency/blood ; Gestational Age ; Heart Diseases/blood ; Heart Diseases/epidemiology ; Humans ; Middle Aged ; Pregnancy in Diabetics/epidemiology ; Prevalence ; Prospective Studies ; United Kingdom/epidemiology ; Vitamin B 12 Deficiency/blood ; Vitamin B 12 Deficiency/epidemiology ; Young Adult
    • Abstract:
      Aims/hypothesis: The prevalence of gestational diabetes mellitus (GDM) is increasing worldwide in all ethnic groups. Low vitamin B 12 and low/high folate levels may contribute to GDM risk, but there is conflicting evidence. Our aim is to assess the relationships of early pregnancy vitamin B 12 and folate levels with the risk of GDM status at 26-28 weeks of gestation.
      Methods: This was a prospective, multi-centre, multi-ethnic cohort study (n = 4746) in the UK. Participants who were eligible to be selectively screened as per the National Institute for Health and Care Excellence (NICE) criteria were included in the study.
      Results: GDM prevalence was 12.5% by NICE and 14.7% by International Association of Diabetes and Pregnancy Study Groups (IADPSG) criteria. Folate deficiency (1.3%) was rare but B 12 insufficiency (42.3% at <220 pmol/l) and folate excess (36.5%) were common in early pregnancy. Early pregnancy median B 12 levels were lower, and folate levels higher, in women who were diagnosed with GDM at 26-28 weeks. B 12 was negatively associated with fasting plasma glucose (1 SD: -0.06 mmol/l; 95% CI -0.04, -0.08; p < 0.0001) and 2 h plasma glucose levels (-0.07 mmol/l; 95% CI -0.02, -0.12; p = 0.004). Higher B 12 was associated with 14.4% lower RR of IADPSG-GDM (0.856; 95% CI 0.786, 0.933; p = 0.0004) after adjusting for key confounders (age, parity, smoking status, ethnicity, family history, household income and folate status). Approximately half of this association was mediated through BMI. Folate was positively associated with 2 h plasma glucose levels (0.08 mmol/l; 95% CI 0.04, 0.13; p = 0.0005) but its relationship with fasting plasma glucose was U-shaped (quadratic β: 0.011; p = 0.05). Higher folate was associated with 11% higher RR of IADPSG-GDM (adjusted RR 1.11; 95% CI 1.036, 1.182; p = 0.002) (age, parity, smoking status, ethnicity, family history, household income and B 12 status). Although no interactions were observed for B 12 and folate (as continuous variables) with glucose levels and GDM risk, a low B 12 -high folate combination was associated with higher blood glucose level and risk of IADPSG-GDM (adjusted RR 1.742; 95% CI 1.226, 2.437; p = 0.003).
      Conclusions/interpretation: B 12 insufficiency and folate excess were common in early pregnancy. Low B 12 and high folate levels in early pregnancy were associated with small but statistically significant changes in maternal blood glucose level and higher RR of GDM. Our findings warrant additional studies on the role of unmetabolised folic acid in glucose metabolism and investigating the effect of optimising early pregnancy or pre-conception B 12 and folate levels on subsequent hyperglycaemia.
      Trial Registration: ClinicalTrials.gov NCT03008824.
      (© 2021. The Author(s).)
    • Comments:
      Comment in: Clin Chem Lab Med. 2022 Jun 09;60(10):1493-1495. (PMID: 35675909)
    • References:
      Diabetes Care. 2016 Jun;39(6):982-7. (PMID: 27208333)
      Am J Clin Nutr. 2018 Aug 1;108(2):398-404. (PMID: 29982347)
      BMJ Open. 2016 Aug 12;6(8):e011247. (PMID: 27519920)
      Am J Epidemiol. 2017 Feb 1;185(3):212-223. (PMID: 28108470)
      Diabet Med. 2014 Mar;31(3):263-72. (PMID: 24344881)
      N Engl J Med. 2013 Jan 10;368(2):149-60. (PMID: 23301732)
      Clin Chem. 1999 Aug;45(8 Pt 1):1261-8. (PMID: 10430793)
      Eur J Endocrinol. 2004 Oct;151(4):483-9. (PMID: 15476449)
      Cell. 2017 Oct 5;171(2):372-384.e12. (PMID: 28942920)
      Clin Chem. 2004 Jan;50(1):3-32. (PMID: 14709635)
      Clin Nutr. 2018 Jun;37(3):940-947. (PMID: 28381340)
      N Engl J Med. 2005 Jun 16;352(24):2477-86. (PMID: 15951574)
      Epigenetics. 2019 May;14(5):421-444. (PMID: 30915894)
      N Engl J Med. 2009 Oct 1;361(14):1339-48. (PMID: 19797280)
      Diabetologia. 2009 Nov;52(11):2350-8. (PMID: 19707742)
      Br J Haematol. 2014 Aug;166(4):496-513. (PMID: 24942828)
      Lancet Diabetes Endocrinol. 2017 Aug;5(8):578-579. (PMID: 28732661)
      Epigenetics. 2018;13(2):122-128. (PMID: 27019060)
      J Pregnancy. 2014;2014:123024. (PMID: 24883207)
      Diabetes Care. 2021 Jan;44(1):217-223. (PMID: 33158950)
      Nature. 2011 Jun 08;474(7353):649-53. (PMID: 21654750)
      Nutrients. 2016 Dec 01;8(12):. (PMID: 27916927)
      Acta Obstet Gynecol Scand. 2004 Jun;83(6):543-7. (PMID: 15144335)
      Eur J Epidemiol. 2017 Feb;32(2):125-134. (PMID: 27995393)
      J Chromatogr B Analyt Technol Biomed Life Sci. 2016 Feb 15;1012-1013:186-92. (PMID: 26851522)
      Diabetes Care. 2016 Mar;39(3):e36-7. (PMID: 26822325)
      Diabetes Care. 2019 Jul;42(7):e113-e115. (PMID: 31076420)
      Metabolism. 2003 Jun;52(6):720-3. (PMID: 12800097)
      Am J Clin Nutr. 2016 May;103(5):1232-51. (PMID: 27076577)
      Lancet Diabetes Endocrinol. 2020 Sep;8(9):793-800. (PMID: 32822601)
      Diabetes Care. 2010 Mar;33(3):676-82. (PMID: 20190296)
      Proc Natl Acad Sci U S A. 2007 Dec 4;104(49):19351-6. (PMID: 18042717)
      Endocrine. 2019 Nov;66(2):149-156. (PMID: 31463884)
      Arch Gynecol Obstet. 2006 Oct;274(6):333-7. (PMID: 16770586)
      Diabetes Care. 2019 Jun;42(6):1034-1041. (PMID: 31010874)
      BMC Public Health. 2019 Feb 26;19(1):231. (PMID: 30808311)
      Nat Med. 2011 Apr;17(4):448-53. (PMID: 21423183)
      J Clin Endocrinol Metab. 2017 Nov 1;102(11):4200-4209. (PMID: 28938471)
      Clin Epigenetics. 2015 Feb 27;7:14. (PMID: 25763114)
      Am J Clin Nutr. 2020 Nov 11;112(5):1390-1403. (PMID: 33022704)
      Diabetologia. 2017 Mar;60(3):399-405. (PMID: 27913848)
      PLoS One. 2014 Apr 14;9(4):e94863. (PMID: 24733310)
      Am J Clin Nutr. 2012 Jan;95(1):130-6. (PMID: 22170376)
      Nutrients. 2020 Jun 29;12(7):. (PMID: 32610503)
      Annu Rev Anim Biosci. 2019 Feb 15;7:263-287. (PMID: 30412672)
      PLoS One. 2015 Aug 19;10(8):e0135268. (PMID: 26288227)
      Front Endocrinol (Lausanne). 2017 Nov 23;8:315. (PMID: 29218028)
    • Grant Information:
      MR/J000094/1 United Kingdom MRC_ Medical Research Council
    • Contributed Indexing:
      Keywords: Folate; Folic acid; Gestational diabetes mellitus; Micronutrients; Pregnancy; Risk factors; Vitamin B12
    • Molecular Sequence:
      ClinicalTrials.gov NCT03008824
    • Accession Number:
      0 (Blood Glucose)
      935E97BOY8 (Folic Acid)
      P6YC3EG204 (Vitamin B 12)
    • Publication Date:
      Date Created: 20210723 Date Completed: 20220318 Latest Revision: 20221229
    • Publication Date:
      20231215
    • Accession Number:
      PMC8423653
    • Accession Number:
      10.1007/s00125-021-05510-7
    • Accession Number:
      34296321